Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Operating Activities
Net Income	$ 10,157	$ 11,382
Adjustments to reconcile net income to net cash flows provided by operating activities:
Change in deferred acquisition costs	(8,209)	(1,546)
Depreciation and amortization	9,661	6,359
Deferred income tax expense	(1,310)	695
Net realized investment (gains) losses	(2,043)	6
Gain on sale of subsidiary	402	0
Stock-based compensation expense	1,033	707
Direct stock awards to employees	29	4
Amortization of premiums and accretion of discounts on investments	1,097	932
Non-controlling interests	868	62
Change in allowance for doubtful accounts	(118)	0
Changes in operating assets and liabilities, net of the effects of acquisitions and dispositions:
Accrued investment income	287	(186)
Accounts and premiums receivable, net	(5,366)	(4,884)
Other receivables	(22,716)	(6,897)
Reinsurance receivables	(7,647)	(2,444)
Income taxes receivable	2,919	(914)
Other assets	(1,395)	2,224
Unpaid claims	264	(542)
Unearned premiums	13,771	3,185
Policyholder account balances	(1,620)	(1,817)
Accrued expenses, accounts payable and other liabilities	18,942	16,684
Income taxes payable	222	(1,344)
Deferred revenue	14,145	(1,187)
Net cash flows provided by operating activities	22,569	20,479
Investing Activities:
Proceeds from maturities, calls and prepayments of available-for-sale investments	7,963	6,501
Proceeds from sales of available-for-sale investments	54,663	4,980
Net change in short-term investments	251	100
Purchases of available-for-sale investments	(78,739)	(31,934)
Purchases of property and equipment	(2,971)	(5,145)
Net paid for acquisitions of subsidiaries, net of cash received	(3,112)	(45)
Sale of subsidiary, net of cash paid	2,180	0
Net proceeds from (issuance of) notes receivable	(663)	(678)
Net proceeds from related party notes receivable	6,135	0
Change in restricted cash	2,350	(7,052)
Net cash flows used in investing activities	(11,943)	(33,273)
Financing activities
Payments on notes payable	(19,188)	(126,200)
Proceeds from notes payable	12,500	124,368
Capitalized closing costs for notes payable		1,692
Net proceeds from exercise of stock options	49	19
Repurchase of shares of common stock, net of issuances	(1,372)	(3,923)
Net proceeds from stock issued in the Employee Stock Purchase Plan	152	167
Distributions to non-controlling interest partners	(720)	0
Dividends paid to non-controlling interests	(43)	0
Net cash flows used in financing activities	(8,622)	(7,261)
Net increase (decrease) in cash and cash equivalents	2,004	(20,055)
Cash and cash equivalents, beginning of period	$ 15,209	$ 31,339